SCHEMBL18309

SCHEMBL18309

OCC1CCC(CF)(CF)CC1

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9156224 0.79 APLNR (0.36) APLNR
SCHEMBL25307674 0.78 APLNR (0.37) APLNR
SCHEMBL22907 0.74 APLNR (0.55) APLNR
SCHEMBL16718804 0.74 APLNR (0.55) APLNR
SCHEMBL15536695 0.74 TSHR (0.33)
SCHEMBL26980842 0.72 APLNR (0.46) APLNR
SCHEMBL3060885 0.71 POLB (0.33) APLNR
SCHEMBL16886414 0.71 POLB (0.33) APLNR
SCHEMBL16875514 0.71 POLB (0.33) APLNR
SCHEMBL3025238 0.70 APLNR (0.38) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855428-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN Genentech, Inc. (US) 2015-04-08 EP disclosed
WO-2013177224-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN GENENTECH, INC. (US) 2013-11-28 WO disclosed
WO-2012025857-A1 CYCLOALKYL METHOXYBENZYL PHENYL PYRAN DERIVATIVES AS SODIUM DEPENDENT GLUCOSE CO TRANSPORTER (SGLT2) INHIBITORS HETERO RESEARCH FOUNDATION (IN) 2012-03-01 WO disclosed